Friday 6 November 2026 Export ATR’s income statement to Excel — free account

AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue: +6.03%
EPS: −73.9%
Free cash flow: −16.9%
Total debt: +14.6%

Quarter to September 2026, against a year earlier

143.84 3.02 −2.06%

Follow ATR

Alert me

Market cap: $9.1B
P/E: 34.6×
Fwd P/E: 25.9×
Dividend yield: 1.00%
F-score: 5/9
Altman Z: 3.78
Beneish M: −2.48
Dividend safety: 92/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

AptarGroup, Inc. (ATR) revenue by segment, product and region

	Q4 FY2017	Q3 FY2017	Q2 FY2017	Q1 FY2017	Q4 FY2016	Q3 FY2016	Q2 FY2016	Q1 FY2016	Q4 FY2015	Q3 FY2015	Q2 FY2015	Q1 FY2015
Pumps	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Closures Product	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Valves	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other Product	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Injectables	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other, not broken out	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Revenue	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.

AptarGroup, Inc. (ATR) revenue by segment, product and region

Stockrow Weekly